Pharma IPR USA 2019

Pharma IPR USA 2019 is a conference dedicated to Intellectual Property (IP) in the pharmaceuticals Industry as the backbone to ensure development of new treatments and cures.

Topics

• Legal Perspective on Paragraph IV Proceedings
• Overview on Hatch-Waxman Act and Its Impact on Drug Development Process
• Interplay between Patent Law and Reproducibility
• FDA Drivers for ANDA Filing and Litigation
• Analysis of Emerging Doctrine of Equivalents (DOE) in ANDA Cases
• Industry Insights on Hatch-Waxman and Paragraph IV Litigations
• Induced Infringement - Permissibility and Inevitability

Who should Attend

Senior attendees from biopharma & pharmaceuticals industry as well as IP attorneys and counsels.